
0.4506 Delayed Data As of Sep 22 | ![]() Today’s Change | 0.43 Today|||52-Week Range 1.00 | -18.07% Year-to-Date |
Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock? Sep 22 / Zacks.com - Paid Partner Content |
Previous close | 0.45 |
Today’s open | 0.46 |
Day’s range | 0.45 - 0.46 |
Volume | 240 |
Average volume (3 months) | 299,149 |
Market cap | $53.4M |
Earnings growth (last year) | -22.29% |
Earnings growth (this year) | +24.59% |
Earnings growth (next 5 years) | 0.00% |
Revenue growth (last year) | -4.57% |
P/E ratio | NM |
Price/Sales | 5.05 |
Price/Book | 0.94 |
Today’s change | Today’s % change | |
---|---|---|
DYAIDyadic International... | 0.00 | 0.00% |
VTGNVistagen Therapeutic... | +0.11 | +2.14% |
AGLEAeglea Bio Therapeut... | +0.43 | +3.68% |
OTLKOutlook Therapeutics... | +0.00 | +0.57% |
Next reporting date | November 7, 2023 |
EPS forecast (this quarter) | -$0.11 |
Annual revenue (last year) | $10.2M |
Annual profit (last year) | -$56.7M |
Net profit margin | -557.69% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |